ARTICLE | Clinical News
Connexios preclinical data
July 4, 2011 7:00 AM UTC
In prediabetic rats, oral CNX-011-67 for 7 weeks significantly enhanced insulin secretion and delayed the onset of fasting glycemia vs. vehicle-treated controls (p<0.01 for both). The free fatty acid...